ENMD-2076
-
Catalog numberB1938-25
-
PricePlease ask
-
Size25 mg
-
-
Alternative_name6-(4-methylpiperazin-1-yl)-N-(5-methyl-1H-pyrazol-3-yl)-2-[(E)-2-phenylethenyl]pyrimidin-4-amine
-
DescriptionENMD-2076 is a selective inhibitor of Aurora A and Flt3 with IC₅₀ values of 14 and 1.86 nM, respectively. Displays 5-fold selectivity for Aurora A than over Aurora B and less potent to VEGFR2/KDR and VEGFR3, FGFR1 and FGFR2 and PDGFRα.
-
CAS Number934353-76-1
-
Structure AvailableYes
-
Salt FormNo
-
Molecular FormulaC₂₁H₂₅N₇
-
Molecular Weight375.47
-
Cell PermeableYes
-
Purity≥98% by HPLC
-
SolubilitiesDMSO (~ 18 mg/ml)
-
HandlingProtect from air and light
-
Tag LineA selective inhibitor of Aurora A and Flt3
-
Storage Condition-20°C
-
Shipping Conditiongel pack
-
Shelf Life36 months
-
PubChem CID16041424
-
SMILESCC1=CC(=NN1)NC2=NC(=NC(=C2)N3CCN(CC3)C)C=CC4=CC=CC=C4
-
InChiInChI=1S/C21H25N7/c1-16-14-20(26-25-16)23-19-15-21(28-12-10-27(2)11-13-28)24-18(22-19)9-8-17-6-4-3-5-7-17/h3-9,14-15H,10-13H2,1-2H3,(H2,22,23,24,25,26)/b9-8+
-
InChi KeyBLQYVHBZHAISJM-CMDGGOBGSA-N
-
MSDS AvailableYes
-
Gene target
-
Short nameENMD-2076
-
Alternative nameENMD-2076
-